US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 11.700
  • -10.660-47.67%
Close Aug 9 16:00 ET
  • 12.740
  • +1.040+8.89%
Post 19:59 ET
539.69MMarket Cap8.73P/E (TTM)

Pacira BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacira BioSciences Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Jul 30, 2024

Revenue(YoY)

178.02M

+5.05%
EPS(YoY)

0.39

-23.53%
Analyst Rating

Strong Buy

Aug 11, 2024

Pacira BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 183.834M--
--2024/Q3-- / 170.720M--
Jul 30, 20242024/Q2178.023M / 173.684M--
May 7, 20242024/Q1167.117M / 165.670M--
Feb 29, 20242023/Q4181.244M / 180.825M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 183.834M--
--2024/Q3-- / 170.720M--
Jul 30, 20242024/Q2178.023M / 173.684M--
May 7, 20242024/Q1167.117M / 165.670M--
Feb 29, 20242023/Q4181.244M / 180.825M--

Unlock Free Earnings Estimates

Pacira BioSciences Earnings Reports

  • Pacira BioSciences | 10-Q: Q2 2024 Earnings Report

    Jul 30 16:07 ET

  • Pacira BioSciences | 10-Q: Q1 2024 Earnings Report

    May 7 16:07 ET

  • Pacira BioSciences | 10-K: FY2023 Annual Report

    Feb 29 15:39 ET

  • Pacira BioSciences | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 14:59 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 11, 2024

    Strong Buy

    • Buy

      90.00%

    • Hold

      10.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg